Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FBMS
13951
CALL
DELISTED
The First Bancshares, Inc.
FBMS
| $3.5K | ﹤0.01% |
+100
| New | +$3.48K |
2024 Q4
0 quarters
|
|
13952
CALL
South Plains Financial
SPFI
$802M
| $3.48K | ﹤0.01% |
100
-1,200
| -92% | -$43.5K |
2024 Q1
3 quarters
|
|
13953
CALL
Invesco Global Clean Energy ETF
PBD
$116M
| $3.47K | ﹤0.01% |
300
-2,000
| -87% | -$25K |
2024 Q2
2 quarters
|
|
13954
CALL
Enel Chile
ENIC
$5.98B
| $3.46K | ﹤0.01% |
1,200
-5,100
| -81% | -$14.2K |
2024 Q3
1 quarter
|
|
13955
PUT
Global Water Resources
GWRS
$230M
| $3.45K | ﹤0.01% |
300
-1,500
| -83% | -$18.8K |
2022 Q4
8 quarters
|
|
|
SLN
13956
CALL
Silence Therapeutics
SLN
$640M
| $3.44K | ﹤0.01% |
500
+200
| +67% | +$2.58K |
2024 Q3
1 quarter
|
|
|
DMYY.WS
13957
DELISTED
dMY Squared Technology Group Warrants
DMYY.WS
| $3.41K | ﹤0.01% |
14,511
-319
| -2% | -$62 |
2022 Q4
8 quarters
|
|
13958
PUT
BrightSpring Health Services
BTSG
$12.2B
| $3.41K | ﹤0.01% |
200
-500
| -71% | -$8.65K |
2024 Q1
3 quarters
|
|
|
IVAC
13959
PUT
DELISTED
Intevac Inc
IVAC
| $3.4K | ﹤0.01% |
1,000
-8,000
| -89% | -$25.3K |
2022 Q1
11 quarters
|
|
13960
CALL
Pulmonx
LUNG
$80.7M
| $3.4K | ﹤0.01% |
500
+200
| +67% | +$1.32K |
2022 Q4
8 quarters
|
|
|
SASR
13961
PUT
DELISTED
Sandy Spring Bancorp Inc
SASR
| $3.37K | ﹤0.01% |
100
-100
| -50% | -$3.49K |
2024 Q1
3 quarters
|
|
13962
PUT
TXO Partners LP
TXO
$780M
| $3.37K | ﹤0.01% |
+200
| New | +$3.63K |
2024 Q4
0 quarters
|
|
13963
CALL
Codexis
CDXS
$149M
| $3.34K | ﹤0.01% |
700
+600
| +600% | +$2.47K |
2022 Q4
8 quarters
|
|
13964
ProShares Short Financials
SEF
$17.8M
| $3.33K | ﹤0.01% |
94
-1,094
| -92% | -$39.3K |
2024 Q2
2 quarters
|
|
13965
PUT
Concrete Pumping Holdings
BBCP
$495M
| $3.33K | ﹤0.01% |
500
+400
| +400% | +$2.46K |
2024 Q3
1 quarter
|
|
13966
CALL
Paysign
PAYS
$822M
| $3.32K | ﹤0.01% |
1,100
-16,400
| -94% | -$57.5K |
2019 Q2
22 quarters
|
|
|
BCTX
13967
PUT
Briacell Therapeutics
BCTX
$35.8M
| $3.28K | ﹤0.01% |
+39
| New | +$4.67K |
2024 Q4
0 quarters
|
|
13968
PUT
Sight Sciences
SGHT
$478M
| $3.28K | ﹤0.01% |
900
+400
| +80% | +$1.82K |
2024 Q1
3 quarters
|
|
13969
PUT
Smith Micro Software
SMSI
$15M
| $3.27K | ﹤0.01% |
500
+312
| +166% | +$1.44K |
2019 Q3
21 quarters
|
|
13970
PUT
Acurx Pharmaceuticals
ACXP
$5.5M
| $3.26K | ﹤0.01% |
200
-285
| -59% | -$8.58K |
2023 Q4
4 quarters
|
|
13971
PUT
Sera Prognostics
SERA
$82.4M
| $3.26K | ﹤0.01% |
+400
| New | +$2.94K |
2024 Q4
0 quarters
|
|
|
BLRX
13972
BioLineRX
BLRX
$11.4M
| $3.25K | ﹤0.01% |
+383
| New | +$5.65K |
2024 Q4
0 quarters
|
|
13973
PUT
WesBanco
WSBC
$3.63B
| $3.25K | ﹤0.01% |
100
-100
| -50% | -$3.31K |
2024 Q1
3 quarters
|
|
|
HIVE
13974
HIVE Digital Technologies
HIVE
$790M
| $3.25K | ﹤0.01% |
1,140
-257
| -18% | -$963 |
2023 Q1
7 quarters
|
|
|
YALA
13975
CALL
Yalla Group
YALA
$818M
| $3.25K | ﹤0.01% |
800
-33,800
| -98% | -$145K |
2021 Q1
15 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.